Creative Biolabs-Immuno-oncology

Anti-CEACAM1 (clone XP1G0Z) SynExpress T7-R-I4-H Modified CD8+ T cells (CAT#: ITS-1224-CR789)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CEACAM1 (clone XP1G0Z). We employs the HBV (T7-RFP-IL-4-HindIII) vector components and the SynExpress system of the miRNA Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CEACAM1
Clone
XP1G0Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.95
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.